Have questions? Visit https://www.reddit.com/r/SNPedia

rs11540652

From SNPedia

Orientationminus
Stabilizedminus
Geno Mag Summary
(A;G) 7 Li-Fraumeni Syndrome (predicted)
(C;C) 0
(C;G) 7 Li-Fraumeni Syndrome (predicted)
(G;G) 0 common in clinvar
(G;T) 7 Li-Fraumeni Syndrome (predicted)


Make rs11540652(A;A)
ReferenceGRCh38 38.1/141
Chromosome17
Position7674220
GeneTP53
is asnp
is mentioned by
dbSNPrs11540652
dbSNP (classic)rs11540652
ClinGenrs11540652
ebirs11540652
HLIrs11540652
Exacrs11540652
Gnomadrs11540652
Varsomers11540652
LitVarrs11540652
Maprs11540652
PheGenIrs11540652
Biobankrs11540652
1000 genomesrs11540652
hgdprs11540652
ensemblrs11540652
geneviewrs11540652
scholarrs11540652
googlers11540652
pharmgkbrs11540652
gwascentralrs11540652
openSNPrs11540652
23andMers11540652
SNPshotrs11540652
SNPdbers11540652
MSV3drs11540652
GWAS Ctlgrs11540652
Max Magnitude7

rs11540652, also known as c.743G>A, Arg248Gln or R248Q, is a SNP in the p53 TP53 tumor suppressor gene. Note that c.743G>C (p.Arg248Pro or R248P) and c.743G>T (p.Arg248Leu or R248L) are also known variants.

The rare rs11540652(A) allele is associated with predisposition to cancer in the form of Li-Fraumeni syndrome 1; the other two variant alleles are considered likely to be pathogenic as well by ClinVar submitters, and may be even rarer.[PMID 1683921]

The rs11540652(A) mutation is consistently denoted as pathogenic (causal) in ClinVar; see also OMIM 191170.0010.

This variant meets the criteria published in 2013 by the ACMG regarding incidental findings in exome or genome sequencing, as a variant that they do recommend informing a patient about.[PMID 23788249OA-icon.png]

? (A;A) (A;G) (G;G) 28


OMIM191170
DescLI-FRAUMENI SYNDROME 1
Variant0010
Relatedalso



ClinVar
Risk rs11540652(A;A) Rs11540652(C;C) rs11540652(T;T)
Alt rs11540652(A;A) Rs11540652(C;C) rs11540652(T;T)
Reference Rs11540652(G;G)
Significance Other
Disease Hereditary cancer-predisposing syndrome Uterine Carcinosarcoma Transitional cell carcinoma of the bladder Neoplasm of brain Squamous cell carcinoma of lung Brainstem glioma Medulloblastoma Myelodysplastic syndrome Pancreatic adenocarcinoma Squamous cell carcinoma of the head and neck Adenocarcinoma of lung Acute myeloid leukemia Chronic lymphocytic leukemia Ovarian Serous Cystadenocarcinoma Adenocarcinoma of stomach Small cell lung cancer Squamous cell carcinoma of the skin Hepatocellular carcinoma Neoplasm of breast Oesophageal carcinoma Multiple myeloma Colorectal Neoplasms Glioblastoma Malignant melanoma of skin Adenocarcinoma of prostate Malignant neoplasm of body of uterus Li-Fraumeni syndrome Li-Fraumeni syndrome 1 Sarcoma Li-Fraumeni syndrome 2 not provided Neoplasm
Variation info
Gene TP53
CLNDBN Hereditary cancer-predisposing syndrome Uterine Carcinosarcoma Transitional cell carcinoma of the bladder Neoplasm of brain Squamous cell carcinoma of lung Brainstem glioma Medulloblastoma Myelodysplastic syndrome Pancreatic adenocarcinoma Squamous cell carcinoma of the head and neck Adenocarcinoma of lung Acute myeloid leukemia Chronic lymphocytic leukemia Ovarian Serous Cystadenocarcinoma Adenocarcinoma of stomach Small cell lung cancer Squamous cell carcinoma of the skin Hepatocellular carcinoma Neoplasm of breast Oesophageal carcinoma Multiple myeloma Colorectal Neoplasms Glioblastoma Malignant melanoma of skin Adenocarcinoma of prostate Malignant neoplasm of body of uterus Li-Fraumeni syndrome Li-Fraumeni syndrome 1 Sarcoma Li-Fraumeni syndrome 2 not provided Neoplasm
Reversed 1
HGVS NC_000017.10:g.7577538C>A; NC_000017.10:g.7577538C>G; NC_000017.10:g.7577538C>T
CLNSRC OMIM Allelic Variant UniProtKB (protein)
CLNACC RCV000219834.2, RCV000417894.1, RCV000418531.1, RCV000422303.1, RCV000422821.1, RCV000423159.1, RCV000423468.1, RCV000424119.1, RCV000424394.1, RCV000427307.1, RCV000428586.1, RCV000429221.1, RCV000430044.1, RCV000433237.1, RCV000433865.1, RCV000434177.1, RCV000435101.1, RCV000435726.1, RCV000437940.1, RCV000439516.1, RCV000439901.1, RCV000440686.1, RCV000443630.1, RCV000443712.1, RCV000445145.1, RCV000445266.1, RCV000229442.2, RCV000418894.1, RCV000419610.1, RCV000420292.1, RCV000420936.1, RCV000421633.1, RCV000424795.1, RCV000425414.1, RCV000425773.1, RCV000426089.1, RCV000430314.1, RCV000430964.1, RCV000431663.1, RCV000432304.1, RCV000432999.1, RCV000434831.1, RCV000435488.1, RCV000436124.1, RCV000436850.1, RCV000438849.1, RCV000441018.1, RCV000441674.1, RCV000443867.1, RCV000444130.1, RCV000444805.1, RCV000445077.1, RCV000013150.22, RCV000115736.8, RCV000148913.1, RCV000179773.1, RCV000197114.3, RCV000235221.2, RCV000417916.1, RCV000419135.1, RCV000420303.1, RCV000420727.1, RCV000421194.1, RCV000421893.1, RCV000424869.1, RCV000426233.1, RCV000426359.1, RCV000426606.1, RCV000427709.1, RCV000428591.1, RCV000430513.1, RCV000432587.1, RCV000432778.1, RCV000433424.1, RCV000435533.1, RCV000437291.1, RCV000437518.1, RCV000437935.1, RCV000438410.1, RCV000439963.1, RCV000441226.1, RCV000444656.1, RCV000445235.1, RCV000445244.1,



[PMID 18798306OA-icon.png] Construction of a high resolution linkage disequilibrium map to evaluate common genetic variation in TP53 and neural tube defect risk in an Irish population.


[PMID 21264207OA-icon.png] Detection of somatic mutations by high-resolution DNA melting (HRM) analysis in multiple cancers.